Paganetti, Harald
Harvard Medical School,
United States
2025 Rank: 2810
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2 out of 122662 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2810 | 2858 |
| Total Cites | 1823 | 2061 |
| H-index | 19 | 19 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 284 | 289 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 525 | 556 |
| Number of Single+First+Last Authored Papers | 256 | 256 |
| Total Cites to Single+First+Last Authored Papers | 1234 | 1342 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 950 | 1011 |
| Ratio of Total Citations to Distinct Citing Papers | 1.92 | 2.04 |
| Self-Citation Percentage |
11.55%
|
|
Paganetti, Harald
Harvard Medical School,
United States
2024 Rank: 4207
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 4 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4207 | 4163 |
| Total Cites | 1544 | 1727 |
| H-index | 17 | 17 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 252 | 256 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 415 | 437 |
| Number of Single+First+Last Authored Papers | 254 | 254 |
| Total Cites to Single+First+Last Authored Papers | 1027 | 1118 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 824 | 868 |
| Ratio of Total Citations to Distinct Citing Papers | 1.87 | 1.99 |
| Self-Citation Percentage |
10.60%
|
|
Paganetti, Harald
Massachusetts General Hospital,
United States
2023 Rank: 4198
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 4 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4198 | 4346 |
| Total Cites | 1559 | 1763 |
| H-index | 18 | 18 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 38 | 38 |
| Total Cites to Single Authored Papers | 236 | 242 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 419 | 440 |
| Number of Single+First+Last Authored Papers | 249 | 249 |
| Total Cites to Single+First+Last Authored Papers | 1053 | 1144 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 802 | 850 |
| Ratio of Total Citations to Distinct Citing Papers | 1.94 | 2.07 |
| Self-Citation Percentage |
11.57%
|
|
Paganetti, Harald
Harvard Medical School,
United States
2022 Rank: 4700
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 5 out of 105572 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4700 | 3766 |
| Total Cites | 1483 | 1775 |
| H-index | 15 | 17 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 234 | 246 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 394 | 428 |
| Number of Single+First+Last Authored Papers | 242 | 242 |
| Total Cites to Single+First+Last Authored Papers | 1022 | 1177 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 704 | 760 |
| Ratio of Total Citations to Distinct Citing Papers | 2.11 | 2.34 |
| Self-Citation Percentage |
16.45%
|
|
Paganetti, Harald
Massachusetts General Hospital,
United States
2021 Rank: 4036
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 5 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4036 | 3632 |
| Total Cites | 2135 | 2494 |
| H-index | 21 | 24 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 360 | 371 |
| Number of Single+First Authored Papers | 63 | 63 |
| Total Cites to Single+First Authored Papers | 563 | 600 |
| Number of Single+First+Last Authored Papers | 231 | 231 |
| Total Cites to Single+First+Last Authored Papers | 1474 | 1649 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1016 | 1093 |
| Ratio of Total Citations to Distinct Citing Papers | 2.10 | 2.28 |
| Self-Citation Percentage |
14.39%
|
|
Paganetti, Harald
Massachusetts General Hospital,
United States
2020 Rank: 3782
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 4 out of 84246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3782 | 3371 |
| Total Cites | 1610 | 1929 |
| H-index | 19 | 20 |
| Hm-index | 10 | 12 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 281 | 295 |
| Number of Single+First Authored Papers | 61 | 61 |
| Total Cites to Single+First Authored Papers | 452 | 487 |
| Number of Single+First+Last Authored Papers | 223 | 223 |
| Total Cites to Single+First+Last Authored Papers | 1126 | 1275 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 807 | 865 |
| Ratio of Total Citations to Distinct Citing Papers | 2.00 | 2.23 |
| Self-Citation Percentage |
16.54%
|
|